74 related articles for article (PubMed ID: 3756365)
21. Effective control of cisplatin induced emesis by combination drug regimen.
Misra R; Agarwal N
Indian J Cancer; 1994 Mar; 31(1):19-22. PubMed ID: 8063331
[TBL] [Abstract][Full Text] [Related]
22. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.
Van Belle S; Lichinitser MR; Navari RM; Garin AM; Decramer ML; Riviere A; Thant M; Brestan E; Bui B; Eldridge K; De Smet M; Michiels N; Reinhardt RR; Carides AD; Evans JK; Gertz BJ
Cancer; 2002 Jun; 94(11):3032-41. PubMed ID: 12115394
[TBL] [Abstract][Full Text] [Related]
23. Effective control of moderate-dose cisplatin-induced emesis by a short-course regimen including metoclopramide, chlorpromazine and hydrocortisone: results of a randomized trial with metoclopramide alone.
Pollera CF; Calabresi F
Oncology; 1989; 46(4):238-44. PubMed ID: 2740067
[TBL] [Abstract][Full Text] [Related]
24. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.
Carr BI; Bertrand M; Browning S; Doroshow JH; Presant C; Pulone B; Hill LR
J Clin Oncol; 1985 Aug; 3(8):1127-32. PubMed ID: 4040552
[TBL] [Abstract][Full Text] [Related]
25. Antiemetic efficacy of moderately high-dose metoclopramide in patients receiving varying doses of cisplatin. Controlled comparison with a combination of methylprednisolone and metoclopramide.
Ell C; König HJ; Brockmann P; Domschke S; Domschke W
Oncology; 1985; 42(6):354-7. PubMed ID: 4069550
[TBL] [Abstract][Full Text] [Related]
26. Randomized crossover comparison of high-dose intravenous metoclopramide versus a five-drug antiemetic regimen.
Plezia PM; Alberts DS; Kessler JF; Berens PL; Chase JL; Roe DJ
J Pain Symptom Manage; 1990 Apr; 5(2):101-8. PubMed ID: 2189929
[TBL] [Abstract][Full Text] [Related]
27. Improved control of cisplatin-induced emesis with a combination of high doses of methylprednisolone and metoclopramide: a single-blind randomized trial.
Bécouarn Y; Nguyen BB; David M; Lakdja F; Brunet R; Chauvergne J
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1421-4. PubMed ID: 3595666
[TBL] [Abstract][Full Text] [Related]
28. Betamethasone-dixyrazine combination versus high-dose metoclopramide as antiemetic treatment in doxorubicin and cisplatin chemotherapy.
Sorbe B; Hallén C; Skåre NG; Underskog I
Radiother Oncol; 1989 Jun; 15(2):161-7. PubMed ID: 2762589
[TBL] [Abstract][Full Text] [Related]
29. A prospective, randomized double-blind trial comparing metoclopramide alone with metoclopramide plus dexamethasone in preventing emesis induced by high-dose cisplatin.
Parikh PM; Charak BS; Banavali SD; Koppikar SB; Giri N; Nadkarni P; Saikia TK; Gopal R; Advani SH
Cancer; 1988 Nov; 62(10):2263-6. PubMed ID: 3052785
[TBL] [Abstract][Full Text] [Related]
30. Randomized trial comparing two short courses of moderate-dose metoclopramide for moderate-dose cisplatin-induced emesis.
Pollera CF; Conti EM; De Nigris A; Calabresi F
Oncology; 1987; 44(2):73-7. PubMed ID: 3554084
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of the antiemetic action of metoclopramide against cisplatin-induced emesis by transdermal electrical nerve stimulation.
Saller R; Hellenbrecht D; Bühring M; Hess H
J Clin Pharmacol; 1986 Feb; 26(2):115-9. PubMed ID: 3512620
[TBL] [Abstract][Full Text] [Related]
32. Clinical evaluation of the simultaneous blockade of the dopamine D-2, histamine H-1, and muscarinic cholinergic receptors in cancer chemotherapy-induced emesis: results of a controlled trial.
Martin-Jimenez M; Diaz-Rubio E
Cancer Chemother Pharmacol; 1986; 18(2):168-71. PubMed ID: 2947734
[TBL] [Abstract][Full Text] [Related]
33. Does parenteral magnesium sulfate have an antiemetic effect during chemotherapy with cis-platinum?
Ballmer PE; Reinhart WH
Cancer Chemother Pharmacol; 1989; 24(2):109-12. PubMed ID: 2731311
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors influencing cisplatin-induced emesis. Definition and validation of a predictive logistic model.
Pollera CF; Giannarelli D
Cancer; 1989 Sep; 64(5):1117-22. PubMed ID: 2667749
[TBL] [Abstract][Full Text] [Related]
35. Improved benefit/risk ratio of higher-dose metoclopramide therapy during cisplatin-induced emesis.
Saller R; Hellenbrecht D; Hellstern A; Hess H
Eur J Clin Pharmacol; 1985; 29(3):311-2. PubMed ID: 4076327
[TBL] [Abstract][Full Text] [Related]
36. [Benefit and risk of high-dose metoclopramide in comparison to high-dose haloperidol or triflupromazine in cisplatin-induced vomiting].
Saller R; Hellenbrecht D
Klin Wochenschr; 1985 May; 63(9):428-32. PubMed ID: 4039775
[TBL] [Abstract][Full Text] [Related]
37. High-dose metoclopramide and chlorpromazine in the treatment of cisplatin-induced emesis.
Aasebø U; Slørdal L; Prytz PS; Aarbakke J
Pharmacol Toxicol; 1987 May; 60(5):337-9. PubMed ID: 3303001
[TBL] [Abstract][Full Text] [Related]
38. Continuous infusion of high-dose metoclopramide: comparison of pharmacokinetically adjusted and standard doses for the control of cisplatin-induced acute emesis.
Brechot JM; Dupeyron JP; Delattre C; Chastang C; Laaban JP; Rochemaure J
Eur J Clin Pharmacol; 1991; 40(3):283-6. PubMed ID: 1647955
[TBL] [Abstract][Full Text] [Related]
39. Effect of diphenhydramine on the antiemetic action of metoclopramide against cisplatin-induced emesis in dogs.
Smith WL; Jackson CB; Sancilio LF; Alphin RS
Cancer Treat Rep; 1986 Jul; 70(7):934-5. PubMed ID: 3719589
[No Abstract] [Full Text] [Related]
40. Randomized, double-blind cross-over study of acute cisplatin-induced nausea and vomiting, comparing a new schedule of the combination of metoclopramide and methylprednisolone versus metoclopramide alone.
Díaz-Rubio E; González-Larriba JL; Rosell R; Abad A; Martín M; Valerdi JJ; Barriga JJ
Ann Oncol; 1990 Sep; 1(5):379-80. PubMed ID: 2261379
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
